News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
43
Sources here
16
Companies here
1
Search results Stored financial headlines

Active search

43 matching headlines

Ticker or company: NUTXMain company stories
Clear
Latest

The Globe and Mail Earnings

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported a significant increase in net income and adjusted EBITDA for Q2 2026, primarily due to reduced contract services costs and stock-based compensation, despite a decrease in total revenue. The company is actively expanding its hospital network with new facilities planned and is focused on increasing patient volume and service lines. Management highlighted the positive …

Nutex Health says 5th Circuit vacates parts of 2021 QPA rule, may raise IDR outcomes

Nutex Health announced that the Fifth Circuit has vacated key parts of the July 2021 QPA rules, specifically disallowing "ghost rates" and requiring the inclusion of bonus and incentive payments in QPA calculations. This ruling may lead to increased awarded reimbursements, as a judge …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NASDAQ:NUTX) Trading 8.2% Higher - What's Next?

Nutex Health (NASDAQ:NUTX) shares surged 8.2% to $186.65 in midday trading on Thursday, despite a 64% drop in trading volume compared to its average. Analyst sentiment remains largely positive, with a consensus "Moderate Buy" rating and an average price target of $268.33. The company, …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Nutex Health Inc (NUTX) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 75/100

Nutex Health Inc (NUTX) saw its stock rise by 3.6% to $172.46, yet GuruFocus's GF Value assesses it as significantly overvalued with an intrinsic value of $83.34. Despite a strong GF Score of 75/100 indicating above-average fundamentals, its valuation rank is low, and there's …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NASDAQ:NUTX) Trading Down 5.5% - Here's What Happened

Nutex Health (NASDAQ:NUTX) shares traded down 5.5% on Tuesday, closing at $186.62 with a significant 86% decrease in trading volume. Despite the drop, analyst sentiment remains positive with a "Moderate Buy" consensus and an average price target of $268.33. Institutional investment in Nutex Health …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NUTX) Is Up 29.2% After Swinging From Loss To Q2 Profitability - What's Changed

Nutex Health Inc. (NUTX) reported a significant improvement in its Q2 2026 financial results, swinging from a net loss to a net income of US$65.84 million, despite a decline in revenue. This shift has led to a 29.2% increase in its stock price and …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health jumps 21%, continuing post-earnings run (NUTX:NASDAQ)

Nutex Health (NUTX) shares surged nearly 21% on Monday, extending a previous 7% gain after the company's second-quarter earnings release. The stock's recent performance is attributed to strong Q2 earnings, significant net income improvement, and cost reductions, despite a revenue miss. The company's earnings …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Q2 Profit Soars As IDR Cost Reductions Drive Margin Gains

(RTTNews) - Shares of Nutex Health Inc. (NUTX) are up 14.88% today. The company recently reported its second-quarter 2026 financial results, with investors focusing on a sharp improvement in profitability, stronger hospital visit volumes, favorable IDR-related cost reductions and continued operating cash generation. Nutex …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NUTX) Stock Reprices Higher As Profit Surge Meets IDR Risk

Nutex Health (NUTX) stock has seen a significant reprice upwards following a surge in Q2 2026 net income to US$65.8m, reversing a previous loss and highlighting its unexpected profitability. While supporters point to growing hospital volumes and operational improvements, skeptics remain concerned about the …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex outlines 3 hospital openings in H2 2026 while maintaining 3 to 5 openings per year

Earnings Call Insights: Nutex Health (NUTX) Q2 2026 MANAGEMENT VIEW * "It was an active quarter, marked by strong financial results, important reimbursement developments and continued progress on our growth pipeline" (Chairman of the Board & CEO Thomas Vo). * "On the vendor front, …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Nutex Health tops Q2 2026 profit estimates

Nutex Health (NUTX) reported a significant profit beat in Q2 2026, with adjusted earnings of $9.38 per share against an estimate of $4.88, despite revenue slightly missing forecasts at $210.75 million. The company's shares rose over 10% as investors reacted positively to stronger margins, …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc. 2026: Revenue $210.75M, EPS $9.38— 10-Q Summary

Nutex Health Inc. reported strong financial results for the 2026 quarter, with revenue reaching $210.75 million and diluted earnings per share at $9.38. This marks a significant improvement from the prior year's net loss. The company saw hospital patient visits increase, and benefited from …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health Inc. announced strong financial results for the second quarter and first six months of 2026, with net income attributable to Nutex Health significantly increasing to $65.8 million and $112.6 million, respectively, compared to losses and smaller gains in the prior year. The …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Swings to Q2 Profit, Revenue Declines

Nutex Health (NUTX) reported a Q2 net income of $9.38 per diluted share, marking a swing to profit compared to a loss in the prior year. However, the company's revenue for the quarter experienced a decline. Further details require a premium subscription to MT …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Q2 2026 Earnings: Arbitration Cost Relief Lifts Profit Despite Lower Revenue

Nutex Health (NASDAQ: NUTX) reported Q2 2026 revenue of $210.8 million, a 13.6% decrease, but saw diluted EPS improve significantly to $9.38 from a previous loss. This profit increase was driven by a substantial reduction in arbitration-related costs and lower stock-based compensation, which offset …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health in the spotlight as earnings test growth model

Nutex Health Inc. is reporting its second-quarter earnings, which will provide insight into the success of its "capital-light" expansion strategy. Analysts expect earnings of $4.95 per share on $215.03 million in revenue, a sequential decrease from the previous quarter. The report will focus on …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Empowered Funds LLC Takes $3.08 Million Position in Nutex Health Inc. $NUTX

Empowered Funds LLC has acquired a new stake of 32,451 shares in Nutex Health Inc. (NASDAQ:NUTX), valued at approximately $3.08 million, representing 0.47% of the company. Institutional investors collectively own 5.32% of NUTX, and analysts have a "Moderate Buy" consensus rating with an average …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc. (NUTX) director gains 603 shares through restricted stock unit conversion

Nutex Health Inc. director Cheryl Yvonne Grenas acquired 603 shares of common stock on July 31, 2026, through the exercise and conversion of restricted stock units. These units convert on a one-for-one basis, recorded at $0.0000 per share, increasing her direct holdings to 670 …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NUTX) director acquires 603 shares through RSU conversion

Nutex Health Inc. director Frank E. Jaumot acquired 603 shares of common stock on July 31, 2026, through the conversion of restricted stock units (RSUs). This transaction increased his direct ownership to 753 shares. The RSUs converted on a one-for-one basis, with a reported …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 4 Nutex Health Inc For: 3 August By Investing.com

This article announces the filing of a Form 4 for Nutex Health Inc. on August 3rd. It appears to be a standard notification of insider transaction filings, typical for publicly traded companies. The content itself is very brief and mostly consists of a header …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health (NUTX) director gains 603 shares via restricted stock unit conversion

Nutex Health Inc. director Cheryl Yvonne Grenas acquired 603 shares of common stock on July 31, 2026, through the exercise and conversion of restricted stock units. These units convert on a one-for-one basis, recorded at $0.0000 per share, increasing her direct holdings to 670 …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Preview: Nutex Health to Report Financial Results Post-market on August 06

Nutex Health (NASDAQ:NUTX) is scheduled to announce its financial results post-market on August 6th. The consensus EPS estimate is -$0.04, and the consensus revenue estimate is $106.63 million. Investors will be looking for improvements in the company's financial performance.

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc (NUTX) Institutional Confidence

Nutex Health Inc (NUTX) has an institutional shareholding score of 3.00, placing it 55th out of 75 in the Healthcare Providers & Services industry. Institutional shareholding has increased by 29.61% quarter-over-quarter, with John Hussman being the largest individual institutional shareholder. Other major institutional holders …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc (NUTX) Valuation: PE, PB & Fair Value Analysis

Nutex Health Inc (NUTX) currently holds a valuation score of 9.23, placing it 16th out of 75 companies in the Healthcare Providers & Services industry. Its P/E ratio is 10.58, which is 31.87% below its recent high but 166.87% above its recent low. The …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc (NUTX) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Nutex Health Inc's (NUTX) financial health, noting its strong current financial score of 9.62, which ranks it highly within the Healthcare Providers & Services industry. The company demonstrated robust financial status and high operating efficiency, with a recent …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NUTX|Nutex Health Inc|Price:140.350|Chg%:-8.680

This article provides a comprehensive stock analysis of Nutex Health Inc (NUTX) through TradingKey's Stock Score system. It highlights the company's strong fundamentals and high growth potential, despite a weak short-term market performance. The analysis covers financial health, valuation, earnings forecasts, price momentum, institutional …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc (NUTX) Cash Flow

This article provides a detailed cash flow statement for Nutex Health Inc (NUTX), presenting both annual and quarterly data. It breaks down cash flows into operating, investing, and financing activities, along with key metrics like capital expenditures and free cash flow. The data aims …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc (NUTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a detailed timeline of dividend distributions and stock splits for Nutex Health Inc (NUTX). It highlights that the company has not distributed any dividends in the past five years. However, it lists several merger-related stock splits with various ratios, predominantly occurring …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc Revenue Breakdown – MUN:5LF

Nutex Health Inc. (MUN:5LF) reported a total revenue of 745.21 million EUR last year, with the Hospital segment being the top performer, contributing 718.74 million EUR. The company's revenue primarily came from the United States, which accounted for the entire 745.21 million EUR. This …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nutex Health Inc (NUTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Nutex Health Inc (NUTX) across its various business segments for FY2023Q1. The primary revenue sources include net patient service revenue, capitation revenue, management fees, and SaaS revenue. The data, updated as of March 4, 2025, shows …

NUTX main company
Sharemaestro market context Trend signal active 52 weeks +102.8% NUTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context